CSIMarket
 


Longeveron Inc   (LGVN)
Other Ticker:  
 

Cumulative Longeveron Inc 's Quick Ratio for Trailing Twelve Months Period

LGVN's Quick Ratio for Trailing Twelve Months Period and Cash & cash equivalent, Current Liabilities growth


Select the Comparisons : Select the Ratio:

LGVN Quick Ratio for Trailing Twelve Months Period

(Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
(Dec 31 2021)
IV. Quarter
(Sep 30 2021)
III. Quarter
Y / Y Current Liabilities Growth 164.98 % 117.82 % - - -
Y / Y Cash & cash equivalent Growth - - - - -
Quick Ratio for Trailing Twelve Months Period 2.94 5.63 9.88 14.41 13.18
Total Ranking # 957 # 757 # 525 # 258 # 391
Seq. Current Liabilities Growth 2.68 % 50.75 % 10.55 % 54.85 % -15.59 %
Seq. Cash & cash equivalent Growth - - - 84.73 % -11.31 %


Quick Ratio for Trailing Twelve Months Period Comment
On the trailing twelve months basis Due to unchange in Current Liabilities in the III. Quarter to $4 millions, average cumulative Quick Ratio for Trailing Twelve Months Period decreased to 2.94 below Longeveron Inc average Quick Ratio for Trailing Twelve Months Period.
Quick Ratio for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies operatig within Major Pharmaceutical Preparations industry 318 other companies have achieved higher Quick Ratio for Trailing Twelve Months Period than Longeveron Inc . While overall ranking remained unchanged compare to previous quarter at no. .

What is Quick Ratio?
Learn more about LGVN
Quick Ratio LGVN in the most recent quarter
Quick Ratio for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 319
Sector # 558
S&P 500 # 957


Quick Ratio for Trailing Twelve Months Period Statistics
High Average Low
11.59 6.91 2.82
(Dec 31 2021)   (Sep 30 2022)




Companies with similar average Quick Ratio for Trailing Twelve Months Period for 12 months ending Sep 30 2022, within Major Pharmaceutical Preparations Industry Quick Ratio for Trailing Twelve Months Period
Roivant Sciences Ltd   8.06 
Corcept Therapeutics Inc  7.99 
Vanda Pharmaceuticals Inc   7.98 
Glycomimetics Inc   7.97 
Evoke Pharma Inc   7.91 
Repare Therapeutics Inc   7.90 
Werewolf Therapeutics Inc   7.89 
Advaxis Inc.  7.87 
Concert Pharmaceuticals Inc   7.86 
Ionis Pharmaceuticals Inc.  7.77 
Biovie Inc   7.71 
Phio Pharmaceuticals Corp   7.70 
Dermata Therapeutics Inc   7.54 
Guardion Health Sciences Inc   7.53 
Protagonist Therapeutics inc   7.50 
Scynexis Inc   7.41 
Catalyst Pharmaceuticals Inc   7.34 
Sio Gene Therapies Inc   7.31 
Theriva Biologics inc   7.30 
Entasis Therapeutics Holdings Inc   7.26 
I mab  7.21 
Xoma Corporation  7.20 
Can fite Biopharma Ltd   7.15 
Arbutus Biopharma Corp  7.14 
Cyclacel Pharmaceuticals Inc   7.09 
Gossamer Bio Inc   7.05 
Abcellera Biologics Inc   7.03 
Opiant Pharmaceuticals Inc   6.99 
Landos Biopharma Inc   6.99 
Trevena inc   6.97 


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

VYNT's Profile

Stock Price

VYNT's Financials

Business Description

Fundamentals

Charts & Quotes

VYNT's News

Suppliers

VYNT's Competitors

Customers & Markets

Economic Indicators

VYNT's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071